Lanean...

Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance

Background The majority of adverse drug reactions (ADRs) reported in the summary of product characteristics (SPCs) are based on pivotal clinical trials, performed under controlled conditions and with selected patients. Objectives (1) to observe ADRs in the real-world setting and to evaluate if the s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Clin Pharm
Egile Nagusiak: Fornasier, G., Taborelli, M., Francescon, S., Polesel, J., Aliberti, M., De Paoli, P., Baldo, P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2018
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132980/
https://ncbi.nlm.nih.gov/pubmed/29785683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-018-0653-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!